Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Dopamine transporter | Starlite/ChEMBL | References |
Rattus norvegicus | Serotonin transporter | Starlite/ChEMBL | References |
Rattus norvegicus | Norepinephrine transporter | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.3232 | 0.3718 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.005 | 0.0041 | 0.0047 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.0343 | 0.8694 | 0.8689 |
Plasmodium falciparum | amino acid transporter, putative | 0.005 | 0.0041 | 0.5 |
Schistosoma mansoni | alkaline phosphatase | 0.0343 | 0.8694 | 1 |
Echinococcus granulosus | intestinal type alkaline phosphatase | 0.0343 | 0.8694 | 0.8689 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0292 | 0.7199 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0078 | 0.0877 | 0.1168 |
Brugia malayi | hypothetical protein | 0.005 | 0.0041 | 0.0057 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0292 | 0.7199 | 0.8281 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.005 | 0.0041 | 0.0047 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.0343 | 0.8694 | 0.8689 |
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.3232 | 0.3718 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0387 | 1 | 1 |
Toxoplasma gondii | hypothetical protein | 0.005 | 0.0041 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.0186 | 0.0214 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.005 | 0.0041 | 0.0057 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0292 | 0.7199 | 0.5 |
Plasmodium falciparum | transporter, putative | 0.005 | 0.0041 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0.7199 | 1 |
Echinococcus granulosus | alkaline phosphatase | 0.0343 | 0.8694 | 0.8689 |
Schistosoma mansoni | hypothetical protein | 0.0091 | 0.1261 | 0.145 |
Brugia malayi | hypothetical protein | 0.0162 | 0.335 | 0.4653 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0234 | 0.5492 | 0.5473 |
Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0.7199 | 1 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0292 | 0.7199 | 0.8281 |
Brugia malayi | Cache domain containing protein | 0.0078 | 0.0877 | 0.1219 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.005 | 0.0041 | 0.5 |
Loa Loa (eye worm) | serotonin transporter b | 0.0292 | 0.7199 | 1 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0292 | 0.7199 | 1 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.005 | 0.0041 | 0.0047 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.005 | 0.0041 | 0.0047 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.005 | 0.0041 | 0.0057 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.005 | 0.0041 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0234 | 0.5492 | 0.7614 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0149 | 0.298 | 0.4105 |
Echinococcus multilocularis | alkaline phosphatase | 0.0343 | 0.8694 | 0.8689 |
Schistosoma mansoni | hypothetical protein | 0.0133 | 0.2493 | 0.2868 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.0343 | 0.8694 | 0.8689 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0292 | 0.7199 | 1 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0176 | 0.3773 | 0.3747 |
Loa Loa (eye worm) | hypothetical protein | 0.0162 | 0.335 | 0.4622 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.0343 | 0.8694 | 0.8689 |
Plasmodium vivax | hypothetical protein, conserved | 0.005 | 0.0041 | 0.5 |
Onchocerca volvulus | 0.0292 | 0.7199 | 1 | |
Echinococcus granulosus | serotonin transporter | 0.0292 | 0.7199 | 0.7188 |
Toxoplasma gondii | hypothetical protein | 0.005 | 0.0041 | 0.5 |
Toxoplasma gondii | Sodium:neurotransmitter symporter family protein | 0.005 | 0.0041 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.005 | 0.0041 | 0.0047 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.005 | 0.0041 | 0.0057 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0158 | 0.3232 | 0.3204 |
Brugia malayi | hypothetical protein | 0.0234 | 0.5492 | 0.7628 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.005 | 0.0041 | 0.0047 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0234 | 0.5492 | 0.5473 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0133 | 0.2493 | 0.2462 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.005 | 0.0041 | 0.0047 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.005 | 0.0041 | 0.0047 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.005 | 0.0041 | 0.0047 |
Brugia malayi | Sodium:neurotransmitter symporter family protein 1, putative | 0.005 | 0.0041 | 0.0057 |
Schistosoma mansoni | serine-rich repeat protein | 0.0091 | 0.1261 | 0.145 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0169 | 0.3561 | 0.4095 |
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.0343 | 0.8694 | 0.8689 |
Schistosoma mansoni | alkaline phosphatase | 0.0343 | 0.8694 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0292 | 0.7199 | 1 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.005 | 0.0041 | 0.0047 |
Schistosoma mansoni | sodium-dependent amino acid transporter | 0.005 | 0.0041 | 0.0047 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0176 | 0.3773 | 0.3747 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0085 | 0.109 | 0.1253 |
Schistosoma mansoni | hypothetical protein | 0.0178 | 0.3834 | 0.441 |
Plasmodium vivax | amine transporter, putative | 0.005 | 0.0041 | 0.5 |
Echinococcus multilocularis | serotonin transporter | 0.0292 | 0.7199 | 0.7188 |
Brugia malayi | hypoxia-induced factor 1 | 0.0149 | 0.298 | 0.4139 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0133 | 0.2493 | 0.2462 |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.005 | 0.0041 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 266 nM | Inhibition of [3H]dopamine uptake in DAT in rat striatum | ChEMBL. | 18249549 |
Ki (binding) | = 266 nM | Inhibition of [3H]dopamine uptake in DAT in rat striatum | ChEMBL. | 18249549 |
Ki (binding) | = 1039 nM | Displacement of [3H]WIN from DAT in rat striatum | ChEMBL. | 18249549 |
Ki (binding) | = 1039 nM | Displacement of [3H]WIN from DAT in rat striatum | ChEMBL. | 18249549 |
Ki (binding) | = 1730 nM | Inhibition of [3H]NE uptake in NET in rat cerebral cortex | ChEMBL. | 18249549 |
Ki (binding) | = 1730 nM | Inhibition of [3H]NE uptake in NET in rat cerebral cortex | ChEMBL. | 18249549 |
Ki (binding) | = 9508 nM | Inhibition of [3H]5HT uptake in SERT in rat cerebral cortex | ChEMBL. | 18249549 |
Ki (binding) | = 9508 nM | Inhibition of [3H]5HT uptake in SERT in rat cerebral cortex | ChEMBL. | 18249549 |
Ratio Ki (binding) | = 0.25 | Ratio of [3H]DA uptake to [3H]WIN binding to DAT in rat brain | ChEMBL. | 18249549 |
Ratio Ki (binding) | = 0.25 | Ratio of [3H]DA uptake to [3H]WIN binding to DAT in rat brain | ChEMBL. | 18249549 |
Ratio Ki (binding) | = 6.5 | Ratio of Ki for NET to Ki for DAT in rat brain | ChEMBL. | 18249549 |
Ratio Ki (binding) | = 35.7 | Ratio of Ki for SERT to Ki for DAT in rat brain | ChEMBL. | 18249549 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.